We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.


NICE: MIB on QuikRead go CRP

The National Institute for Health and Care Excellence (NICE) in the UK has created a medtech innovation briefing (MIB) on the QuikRead go for C-reactive protein testing in primary care. “The innovative aspects are that QuikRead go CRP has the potential to provide rapid results by point-of-care testing of a 20 microlitre blood sample, with a reading time of 2 minutes.” Read more: https://www.nice.org.uk/advice/mib78

"MIBs provide a description of the medical technology, including its likely place in therapy, the costs of using the technology and a critical review of the strengths and weaknesses of the relevant published evidence. Their purpose is to provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals."

QuikRead go for C-reactive protein testing in primary care. Medtech innovation briefing [MIB78]. September 2016. https://www.nice.org.uk/advice/mib78


QuikRead go® CRP

Test before prescribing

QuikRead go CRP is a fast and simple rapid test for quantitative determination of C-reactive protein (CRP) in whole blood, serum and plasma with the QuikRead go instrument. The test gives reliable results within minutes and speeds up the path to the right diagnosis. Accurate measurement of C-reactive protein (CRP) can be critical in the clinical management of a patient with symptoms of infection. Read more: QuikRead go CRP and QuikRead go CRP+Hb